Feedback / Questions
prizloncabtagene autoleucel (JNJ-4496) - J&J
https://www.prnewswire.com/news-releases/abelzeta-announces-promising-long-term-outcomes-for-c-car039-a-novel-cd19cd20-bi-specific-car-t-therapy-in-patients-with-rr-b-nhl-at-eha-2025-302482119.html
Jun 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next